Alembic Pharmaceuticals said that CRISIL Ratings has reaffirmed its ‘CRISIL AA+/Stable/CRISIL A1+’ ratings on the bank loan facilities and commercial paper programme of the company.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
